Works by Chen, Chien-Hung

Results: 195
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression.

    Published in:
    Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 509, doi. 10.1159/000536549
    By:
    • Liu, Tsung-Hao;
    • Chen, San-Chi;
    • Rau, Kun-Ming;
    • Lu, Li-Chun;
    • Lin, Po-Ting;
    • Su, Yung-Yeh;
    • Teng, Wei;
    • Lai, Shiue-Wei;
    • Yeh, Ren-Hua;
    • Kao, Tsui-Mai;
    • Lee, Pei-Chang;
    • Wu, Chi-Jung;
    • Chen, Chien-Hung;
    • Hsu, Chih-Hung;
    • Lin, Shi-Ming;
    • Huang, Yi-Hsiang;
    • Chen, Li-Tzong;
    • Cheng, Ann-Lii;
    • Shen, Ying-Chun
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
    By:
    • Chen, Yen-Chun;
    • Chang, Te-Sheng;
    • Chen, Chien-Hung;
    • Cheng, Pin-Nan;
    • Lo, Ching-Chu;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Huang, Jee-Fu
    Publication type:
    Article
    21

    Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community.

    Published in:
    American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 3, p. 416, doi. 10.1038/ajg.2012.445
    By:
    • Wang, Jing-Houng;
    • Chang, Kuo-Chin;
    • Kee, Kwong-Ming;
    • Chen, Pao-Fei;
    • Yen, Yi-Hao;
    • Tseng, Po-Lin;
    • Kuo, Yuan-Hung;
    • Tsai, Ming-Chao;
    • Hung, Chao-Hung;
    • Chen, Chien-Hung;
    • Tai, Wei-Chen;
    • Tsai, Lin-San;
    • Chen, Shu-Chuan;
    • Lin, Sheng-Che;
    • Lu, Sheng-Nan
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1695, doi. 10.1111/apt.16116
    By:
    • Hu, Tsung‐Hui;
    • Yueh‐Hsia Chiu, Sherry;
    • Tseng, Po‐Lin;
    • Chen, Chien‐Hung;
    • Lu, Sheng‐Nan;
    • Wang, Jing‐Houng;
    • Hung, Chao‐Hung;
    • Kee, Kwong‐Ming;
    • Lin, Ming‐Tsung;
    • Chang, Kuo‐Chin;
    • Lin, Meng‐Chih;
    • Chien, Rong‐Nan
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C.

    Published in:
    JGH Open, 2022, v. 6, n. 11, p. 782, doi. 10.1002/jgh3.12825
    By:
    • Chen, Chi‐Yi;
    • Chuang, Wan‐Long;
    • Qin, Albert;
    • Zhang, Wen‐Hua;
    • Zhu, Li‐Ying;
    • Zhang, Guo‐Qiang;
    • Chen, Jyh‐Jou;
    • Lo, Ching‐Chu;
    • Zhou, Xinmin;
    • Mao, Xiaorong;
    • Shang, Jia;
    • Kuo, Hsing‐Tao;
    • Xie, Wen;
    • Chen, Chien‐Hung;
    • Lo, Gin‐Ho;
    • Jun, Dae W;
    • Dang, Shuangsuo;
    • Tsai, Chan‐Yen;
    • Wang, Ting‐Fang;
    • Lai, Hsin‐Hui
    Publication type:
    Article
    50